NCT06996873Not yet recruiting
Aggressive Spinal Hemangioma
Management Of Aggressive Spinal Hemangioma
Source: ClinicalTrials.gov · Last updated 30 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This research is a case series analysis to evaluate aggressive vertebral hemangiomas. It focuses on clinical presentation, diagnostic imaging accuracy (X-ray, MRI, MSCT, angiography), and treatment efficacy. The primary goal is to establish optimal management protocols.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 2 Apr 2025
- Start date
- Jun 2025
- Primary completion date
- Jul 2026
- Lead sponsor
- Assiut University
- NCT number
- NCT06996873
What you commit to
- Study type: Observational
- Planned participants: 30
- From Jun 2025 to the primary completion date, Jul 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with incidentally discovered spinal hemangiomas (asymptomatic cases found during evaluations for unrelated conditions).
Other
- Cases lacking sufficient diagnostic evidence to confirm aggressive spinal hemangioma.
Who the study is looking for
- Patients diagnosed with aggressive spinal hemangiomas based on clinical symptoms and imaging findings.
- Cases confirmed through diagnostic modalities such as X-ray, MRI, MSCT, or angiography.
- Patients presenting with symptoms such as pain, neurological deficits, or spinal instability attributable to the hemangioma.
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.